Carteolol ophthalmic Pregnancy and Breastfeeding Warnings

Carteolol ophthalmic is also known as: Ocupress

Carteolol ophthalmic Pregnancy Warnings

Carteolol ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of increased fetal resorption and decreased fetal weights when rabbits and rats were given doses 1,052 and 5,264 times the maximum recommended human dose, respectively. There are no controlled data in human pregnancy. Carteolol ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.

Carteolol ophthalmic Breastfeeding Warnings

There are no data on the excretion of carteolol ophthalmic into human milk. It is excreted into animal breast milk after oral administration. Other systemic beta-blockers and topical timolol maleate are excreted in milk. In general, most experts recommend monitoring of nursing infants for signs and symptoms of beta-blockade, such as bradycardia and hypoglycemia. The manufacturer recommends caution when administering carteolol ophthalmic to nursing women.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web3)